US Drug Recall Register

Is Pine recalled?

Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-676-01 D-0321-2022
Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-651-01 D-0320-2022
Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-002-01 D-0319-2022
Class II · Moderate risk Terminated

EPINEPHrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-027-01 D-0304-2022
Class II · Moderate risk Terminated

NOREPINEPHRINE 4 mg per 250 mL

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-451-01 D-0303-2022
Class II · Moderate risk Terminated

Carbamazepine 200mg Tablets

Reason Failed Dissolution Specifications

The Harvard Drug Group NDC 0904-6172-61 D-0807-2021
Class II · Moderate risk Terminated

Norepinephrine Bitartrate Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-1153-03 D-0739-2021
Class II · Moderate risk Terminated

NIFEdipine EXTENDED-RELEASE TABLETS

Reason Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

The Harvard Drug Group NDC 0904-7080-61 D-0652-2021
Class II · Moderate risk Terminated

Zyprexa Intramuscular

Reason cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

Eli Lilly & Company NDC 0002-7597-01 D-0720-2021
Class II · Moderate risk Terminated

Xylocaine-MPF with Epinephrine 1:200

Reason Low out of specification results for epinephrine assay.

Fresenius Kabi USA LLC NDC 63323-487-07 D-0651-2021
Class III · Low risk Terminated

Asenapine Sublingual Tablets

Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

SigmaPharm Laboratories LLC NDC 42794-017-10 D-0380-2021